World rank
—
no current market cap
Revenue
—
annual
Net income
—
Employees
—
Rua Bioscience Limited in brief
Rua Bioscience Limited is a listed company in the Pharmaceutical industry, based in New Zealand. Its last known market value was $12 M (January 2024); there is no current figure. Its shares trade under the symbol RUA.NZ (NZX).
Written from the figures on this page, so it changes when they do. The date of each figure is under How current the figures are.
Market cap history
World rank over time
▼ down 3,296 places since 2022
Rank in New Zealand: #89 (Jan 2022) · #91 (Dec 2022) · #98 (Jul 2023) · #100 (Jan 2024)
Peer comparison · Pharmaceutical
| Company | Market cap | P/E | Net margin | Rev. growth |
|---|---|---|---|---|
| Rua Bioscience Limited🇳🇿 | $12 M | — | — | — |
| Eli Lilly and Company🇺🇸 | $1.20 T | 43.4× | 31.9% | +44.7% |
| Johnson & Johnson🇺🇸 | $652.5 B | 40.5× | 16.2% | +6.0% |
| AbbVie Inc.🇺🇸 | $514.0 B | 49.7× | 15.7% | +8.6% |
| Roche Holding AG🇨🇭 | $370.3 B | 29.1× | 19.0% | — |
| Merck & Co., Inc.🇺🇸 | $359.8 B | 146.7× | 3.6% | +1.3% |
| Novartis AG🇨🇭 | $286.8 B | 20.5× | 24.7% | — |
| Amgen Inc.🇺🇸 | $249.2 B | 26.5× | 24.1% | +9.9% |
| AstraZeneca PLC🇬🇧 | $242.6 B | 23.7× | 17.4% | +8.6% |
P/E and margins use trailing 12-month results where available; growth is the latest fiscal year.
Questions, comparisons and similar companies#
Compare head to head
Similar companies by size and industry
- Eli Lilly and Company$1.20 T
- Johnson & Johnson$652.5 B
- AbbVie Inc.$514.0 B
- Roche Holding AG$370.3 B
- Merck & Co., Inc.$359.8 B
- Novartis AG$286.8 B
How current the figures are
- Market cap:
- Jan 5, 2024 (last known)
- Profile updated:
- Nov 4, 2026
How each figure is collected: data sources and methodology. Market caps in US dollars unless you switch the currency.
Work at Rua Bioscience Limited? Verify and update this profile — free
Show Rua Bioscience Limited's ranking on your website Get the badge
The badge updates itself as the ranking changes.